Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal Bacteremia
Sharon S. Rotun*, Virginia McMath*, Dianna J. Schoonmaker, Peggy S. Maupin†, Fred C. Tenover‡, Bertha C. Hill‡, and David M. Ackman†
Author affiliations: *United Hospital Medical Center (UHMC), Port Chester, New York, USA;; †New York State Department of Health, Albany, New York, USA;; ‡Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
Figure. Pulsed-field gel electrophoresis (PFGE) profiles of SmaI digested DNA. Case patient MRSA isolates from December 1997 and January 1998, GISA isolate from March 1998. Nephrologist MRSA isolate from March 1998 and unrelated MRSA isolates.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.